CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January ...

The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...

Claro Advisors LLC lessened its stake in shares of The Cigna Group (NYSE:CI – Free Report) by 35.9% during the fourth quarter ...

Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.

Cigna Group closed $91.51 below its 52-week high ($370.83), which the company achieved on September 16th.

I've been a Cigna Global Health Insurance policyholder for seven years and had never filed a claim until recently. A few weeks ago, I had to undergo a surgical procedure. I first contacted Cigna ...